Diabetes Mellitus Type 3c

1

Review clinical trials related to Diabetes Mellitus Type 3c. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)

The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer will be responsible for the coordination and data management for the Evaluation of a mixed meal test for Diagnosis and characterization of Type 3c diabetes mellitus secondary to pancreatic cancer and chronic pancreatitis (DETECT), which is part of the NIH U01 funded Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). Similar to all studies that will be coordinated and managed by the CDMC, no patient enrollment will occur at MDACC. All patient recruitment will occur at external sites that are a part of the CPDPC, which are listed in the appended DETECT protocol. The data management systems, auditing, and monitoring effort are supported by the CDMC.

Participants needed: 775
Trial details
Age: 30-84Biological sex: AllType: ObservationalSponsor: M.D. Anderson Cancer CenterUpdated: May 29, 2026Locations: 10
Eligibility criteria

All Participants must sign an informed consent indicating that they are aware of... [+11]

Participants must not have any significant medical illnesses (including diabetes... [+13]